OPTIPHARM. CO., LTDOPTIPHARM. CO., LTDOPTIPHARM. CO., LTD

OPTIPHARM. CO., LTD

No trades
See on Supercharts

153710 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Optipharm Co., Ltd. engages in the business of animal disease diagnosis and pharmaceuticals. It operates through the following business divisions: Xenograft, VLP Vaccine, Bacteriophage, Animal Disease Unit, and Human Diagnostic Kit. The Xenograft business division includes Medipig. The VPL Vaccine business division is involved in research and development of vaccine products. The Bacteriophage business division focuses on developing bacteriophages that have the characteristic of eliminating bacteria without affecting animal cells and beneficial bacteria. The Animal Disease Unit business division refers to detecting and diagnosing porcine cytomegalovirus and its kit. The Human Diagnostic Kit business division refers to diagnostic method and kit for simultaneous detection and identification of mycobacterium tuberculosis and nontuberculous mycobacteria. The company was founded on July 27, 2000 and is headquartered in Cheongju-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

153710 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company